CRSA Joins Ryght Research Network to Accelerate Access to Novel
Cancer Therapies
LAGUNA
BEACH, Calif., Jan. 28,
2025 /PRNewswire/ -- Ryght AI, a leading
provider of real-time generative AI solutions for the clinical
research industry, and Cancer Research South Australia (CRSA), a
premier cancer care provider, have announced a strategic
partnership to advance cancer clinical trials in South Australia. Through this collaboration,
CRSA will join the Ryght Research Network, leveraging Ryght AI's
cutting-edge technology to optimize and accelerate clinical trials
for people with cancer.
This collaboration marks a significant step forward in improving
access to novel cancer therapies for patients in South Australia. By integrating Ryght AI's
cutting-edge AI-powered solutions with CRSA's expertise in cancer
care and clinical trials, the partnership aims to streamline
clinical trial processes, minimize administrative challenges, and
connect South Australia with novel
therapies from Ryght's network of trial sponsors and CROs. This
effort is focused on delivering life-saving treatments to patients
more efficiently and effectively.
Simon Arkell, CEO of Ryght AI,
expressed his enthusiasm about the partnership: "We are excited to
welcome CRSA to the Ryght Research Network. Their commitment to
providing state-of-the-art cancer care aligns perfectly with our
mission to revolutionize clinical trials. By leveraging our AI
technology, we aim to help CRSA accelerate patient access to novel
cancer therapies and further establish clinical trials as the gold
standard choice for cancer treatment."
A/Prof. Rohit Joshi, Director and
Medical Oncologist at CRSA, emphasized the transformative impact of
the partnership: "At CRSA, our mission is to provide compassionate,
advanced cancer care. Partnering with Ryght AI marks a significant
milestone in expanding access to innovative clinical trials. By
incorporating Ryght's AI-driven solutions into our workflows, we
aim to enhance operational efficiency, elevate patient care, and
ultimately achieve better outcomes for cancer patients throughout
South Australia."
The Ryght Research Network, now including CRSA, will utilize
advanced generative AI capabilities to provide real-time insights,
enabling research sites to make informed, data-driven decisions
while ensuring robust data security. By automating key processes
such as AI-powered study selection, feasibility assessments, site
selection and activation, and patient referrals, the partnership
aims to transform traditional trial workflows, streamline trial
management and accelerating patient enrollment.
Ryght will implement its AI-driven site technology at CRSA,
seamlessly integrating it with their existing RealTime Clinical
Trial Management systems and Xestro Electronic Medical Records.
About Ryght AI:
Ryght AI, the real-time clinical trials company, is a privately
held healthcare technology company providing next-generation safe
and secure generative artificial intelligence (GenAI) solutions for
the clinical research industry. Ryght's SOC Type 2-compliant
platform and customized research applications streamline clinical
trials, accelerate workflows, and provide real-time communication
for trial sites, sponsors, and CROs. Ryght's base applications are
free of charge to research sites globally.
About CRSA:
Cancer Research South Australia (CRSA) is a leading provider of
state-of-the-art cancer care in South
Australia. CRSA works alongside specialist oncologist,
cancer surgeons, radiation oncologists, and all major medical
specialties to ensure each patient's cancer care is optimized,
individualized, and of the highest standard. CRSA is committed to
improving access for patients to novel cancer therapies through
clinical trials, which have been demonstrated internationally to be
the gold standard choice of treatment for people diagnosed with
cancer.
Media Contact:
Alexia Krispin
AK@ryght.ai
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ryght-ai-and-cancer-research-sa-crsa-partner-to-enhance-cancer-clinical-trials-in-south-australia-302360513.html
SOURCE Ryght
